Pramipexole Dihydrochloride
- Product NDC
- 70771-1330
- 11-digit product format
- 707711330
- Labeler code
- 70771
- Product ID
- 70771-1330_e91fa361-7045-4e19-9ee8-0d2f389a9a6b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pramipexole Dihydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA202891
- Marketing category
- ANDA
- Marketing start
- 2018-04-24
- Marketing end
- 0000-00-00
- Substance
- PRAMIPEXOLE DIHYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70771-1330-3 | 70771133003 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1330-3) | | 2018-04-24 | 0000-00-00 | No | No | Current |
| 70771-1330-4 | 70771133004 | 10 BLISTER PACK in 1 CARTON (70771-1330-4) > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70771-1330-2) | 10 blister pack | 2018-04-24 | 0000-00-00 | No | No | Current |